Brain Protection in Schizophrenia, Mood and Cognitive Disorders

1. Brain Protection in Neuropsychiatric Disorders: Past, Present and Future Challenges
Ehud Susser, Michael S. Ritsner

2. Towards a New Paradigm in Neuroprotection and Neuroplasticity
Dafin F. Muresanu

3. What Protects Patients with Schizophrenia from Developing Alzheimer Pathology?
Hans-Gert Bernstein, Theresia S. Ernst, Uwe Lendeckel, Henrik Dobrowolny, Johann Steiner, Bernhard Bogerts

4. Assessing In Vivo Neurodegeneration in Schizophrenia Using Magnetic Resonance
Jean Théberge

5. Vulnerability of the Brain to Neuropsychiatric Disorders Resulting from Abnormal Thyroid Hormone or Vitamin D Homeostasis
Sarah J. Bailey, Peter J. McCaffery

6. Phosphatidylinositol 3-Kinase/Glycogen Synthase Kinase and Mitogen-Activated Protein Kinase Signalling Cascades in Neuronal Cell Survival: What the Neurotrophins Have Taught Us and Implications For Neuropsychiatric Disorders
Stephen D. Skaper

7. One-Compound-Multi-Targets at Amyloid β Cascade Offered By Bis(7)-Cognitin, a Novel Anti-Alzheimer’s Dimer
Wenming Li, Hongjun Fu, Moussa B.H. Youdim, Yuanping Pang, Yifan Han

8. Common Pathways to Neurodegeneration and Co-morbid Depression
Darcy Litteljohn, Emily Mangano, Shawn Hayley

9. Breakdown of the Blood-Brain Barrier in Stress Alters Cognitive Dysfunction and Induces Brain Pathology: New Perspectives for Neuroprotective Strategies
Hari Shanker Sharma, Aruna Sharma

10. Oxidative Stress and Neurodegeneration: An Inevitable Consequence of Aging? Implications for Therapy
Roberto Rodrigues, David J. Bonda, George Perry, Rudy J. Castellani, Gemma Casadesus, Hyoung-gon Lee, Hyun-Pil Lee, Xinglong Wang, Xiongwei Zhu, Robert B. Petersen, Mark A. Smith

11. Carbon Nanotubes as Electrical Interfaces with Neurons
William Lee, Vladimir Parpura

12. Is a Neuroprotective Therapy Suitable for Schizophrenia Patients?
Michael S. Ritsner

13. Recombinant Human Erythropoietin: Novel Approach to Neuroprotection and Neuroregeneration in Schizophrenia
Hannelore Ehrenreich, Claudia Bartels, Henning Krampe, Martin Begemann

14. Neuroprotective Agents in Mood Disorders: Pathophysiological and Therapeutic Implications
Giacomo Salvadore, Rodrigo Machado-Vieira, Husseini K. Manji

15. Neuroprotection in Bipolar Depression
Chris B. Aiken

16. New Antiepileptic Drugs in Neuropsychiatric Disorders – Basic Mechanisms Related to Clinical Efficacy
Cecilie Johannessen Landmark, Svein I. Johannessen

17. The Neuroprotective Efficacy of Vitamins
Chanoch Miodownik, Vladimir Lerner

18. Smoking and Mental Disorders: Focus on Neuroprotection
Tsafrir Loebl

19. Inhibition of Glycine Transporter-1 Improves the Functional Outcome of Schizophrenia
Christina Hui, Guochuan E. Tsai

20. The Role of Oxytocin in Neuropsychiatric Disorders: Concepts and Mechanisms
Raz Levin, Shany Edelman, Idan Shalev, Richard P. Ebstein, Uriel Heresco-Levy

21. Neuromodulation for Neuropsychiatric Disorders: Novel Techniques -Vagus Nerve Stimulation, Transcranial Magnetic Stimulation, Transcranial Direct Current Stimulation, and Deep Brain Stimulation
Russell J. Andrews

Nyckelord: Biomedicine, Neurosciences, Psychiatry, Biological Psychology, Biomedicine general